High-throughput structural biology of metabolic enzymes and its impact on human diseases.
The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...
Главные авторы: | Yue, W, Oppermann, U |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2011
|
Схожие документы
-
High-throughput structural biology of metabolic enzymes and its impact on human diseases
по: Yue, W, и др.
Опубликовано: (2011) -
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
по: Yue, W, и др.
Опубликовано: (2011) -
Structural genomics and high throughput structural biology /
по: Sundstrom, Michael, и др.
Опубликовано: (2006) -
Structural genomics and drug discovery: Case studies on human metabolic enzymes
по: Oppermann, U, и др.
Опубликовано: (2007) -
Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions.
по: Oppermann, U, и др.
Опубликовано: (2000)